Erdem, D. Et Al. 2019. DDR1 may be a good biomarker for brain tumors.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).

Erdem, D., Buyuksimsek, M., Gunaldi, M., & Sahin, N., (2019). DDR1 may be a good biomarker for brain tumors. . Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America

Erdem, Dilek Et Al. "DDR1 may be a good biomarker for brain tumors.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2019

Erdem, Dilek Et Al. "DDR1 may be a good biomarker for brain tumors.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2019

Erdem, D. Et Al. (2019) . "DDR1 may be a good biomarker for brain tumors.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={Dilek Erdem Et Al. }, title={DDR1 may be a good biomarker for brain tumors.}, congress name={Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2019}}